SCHEMBL18304697

SCHEMBL18304697

Cc1ccc(C(=O)O)cc1C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.53
S1PR1 P21453 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 2/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TSHR P16473 1/20 0.42
SRD5A2 P31213 1/20 0.42
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
ADCY8 P40145 1/20 0.41
ADCY1 Q08828 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CREBBP Q92793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4572063 0.95 KMO (0.46) KMOS1PR1L3MBTL1GAASMN1; SMN2
SCHEMBL10148085 0.91 CREBBP (0.47) KMOGAASMN1; SMN2TSHRCYP1A2
SCHEMBL4951622 0.87 KMO (0.57) KMOS1PR1L3MBTL1GAAPTGDR2
SCHEMBL4946903 0.85 KMO (0.54) KMOS1PR1L3MBTL1GAAPTGDR2
Methyl Alcohol SCHEMBL31596316 0.82 KMO (0.51) KMOS1PR1
SCHEMBL313355 0.81 KMO (0.54) KMOL3MBTL1GAASRD5A2HSD17B10
SCHEMBL448284 0.81 KMO (0.54) KMOSRD5A2
SCHEMBL30952631 0.81 KMO (0.54) KMOSRD5A2
SCHEMBL901167 0.80 KMO (0.53) KMOL3MBTL1GAASRD5A2HSD17B10
SCHEMBL7792659 0.80 CA12 (0.56) KMOPTGDR2TSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307395-B1 SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS ISP INVESTMENTS LLC (US) 2020-08-05 EP disclosed
US-10328003-B2 Solubilizing agents for active or functional organic compounds ISP INVESTMENTS LLC (US) 2019-06-25 US disclosed
US-20180168970-A1 SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS ISP INVESTMENTS LLC (US) 2018-06-21 US disclosed
EP-3307395-A1 SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS ISP Investments LLC (US) 2018-04-18 EP disclosed
WO-2016201260-A1 SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS ISP INVESTMENTS INC. (US) 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10328003-B2 Solubilizing agents for active or functional organic compounds C1S, POLR1C, TYR KMO 2068/4885S1PR1 545/4885L3MBTL1 754/4885
US-20180168970-A1 SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS C1S, POLR1C, TYR KMO 2068/4885S1PR1 545/4885L3MBTL1 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.